These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22958718)

  • 1. Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer.
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Zhu J; Ye YQ; Hu J
    Acad Radiol; 2012 Oct; 19(10):1215-24. PubMed ID: 22958718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of diffusion-weighted imaging for the discrimination of pancreatic lesions: a meta-analysis.
    Wu LM; Xu JR; Hua J; Gu HY; Zhang XF; Lu Q; Hu JN
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):134-42. PubMed ID: 22241215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model.
    Wu LM; Hu JN; Hua J; Liu MJ; Chen J; Xu JR
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1027-35. PubMed ID: 22414092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses?
    Wu LM; Xu JR; Hua J; Gu HY; Chen J; Haacke EM; Hu J
    Magn Reson Imaging; 2013 Feb; 31(2):235-46. PubMed ID: 22902469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis.
    Haghighi M; Shah S; Taneja SS; Rosenkrantz AB
    J Comput Assist Tomogr; 2013; 37(6):980-8. PubMed ID: 24270122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
    Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
    J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Wu LM; Xu JR; Lu Q; Hua J; Chen J; Hu J
    J Gastroenterol Hepatol; 2013 Feb; 28(2):227-34. PubMed ID: 23190006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis.
    Wu LM; Hu J; Gu HY; Hua J; Xu JR
    Eur J Cancer; 2013 Feb; 49(3):572-84. PubMed ID: 23000072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis.
    Wu LM; Xu JR; Liu MJ; Zhang XF; Hua J; Zheng J; Hu JN
    Acad Radiol; 2012 Mar; 19(3):331-40. PubMed ID: 22153656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.
    Wu LM; Xu JR; Ye YQ; Lu Q; Hu JN
    AJR Am J Roentgenol; 2012 Jul; 199(1):103-10. PubMed ID: 22733900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of diffusion-weighted imaging in the localization of prostate cancer.
    Kajihara H; Hayashida Y; Murakami R; Katahira K; Nishimura R; Hamada Y; Kitani K; Kitaoka M; Suzuki Y; Kitajima M; Hirai T; Morishita S; Awai K; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):399-403. PubMed ID: 19019564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
    Kim CK; Choi D; Park BK; Kwon GY; Lim HK
    J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
    Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
    Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy.
    Hara T; Inoue Y; Satoh T; Ishiyama H; Sakamoto S; Woodhams R; Baba S; Hayakawa K
    Magn Reson Imaging; 2012 Oct; 30(8):1091-8. PubMed ID: 22819584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.